Boeker Klaus H W, Haberkorn Christian I, Michels Dirk, Flemming Peer, Manns Michael P, Lichtinghagen Ralf
Department of Gastroenterology and Hepatology, Medizinische Hochschule, D-30623 Hanover, Germany.
Clin Chim Acta. 2002 Feb;316(1-2):71-81. doi: 10.1016/s0009-8981(01)00730-6.
Circulating levels of tissue inhibitor of metalloproteinase (TIMP)-1 and matrix metalloproteinase (MMP)-2 are investigated as parameters for the diagnosis of fibrosis in chronic liver disease. We evaluated their diagnostic potential in comparison to hepatic histology, serum hyaluronate and standard liver function tests.
Commercially available ELISA assays were used to study circulating values of TIMP-1 and MMP-2 (Bindazyme, Biotrak, Quantikine) in patients with chronic hepatitis C (CAH; n=59), hepatitis C virus-induced cirrhosis (n=19) and 30 healthy controls. Hepatic histology was evaluated using the Hepatitis-Activity-Index according to Ishak et al. [J. Hepatol., 22 (1995) 696-699], quantifying separately inflammatory activity and fibrosis.
Normal ranges for TIMP-1 and MMP-2 values differed for the different assays. Nevertheless, the various assays showed similar diagnostic ability and linear correlation. MMP-2 values were similar in controls and in CAH patients with and without fibrosis, but increased significantly in cirrhosis. TIMP-1 values showed a steady increase from normal to CAH without fibrosis, hepatitis with fibrosis, and cirrhosis. The diagnostic potential of serum MMP-2 to detect fibrosis was low with a sensitivity of 7% in the two assays used and an overall diagnostic efficiency of 56% and 58%. The potential of circulating MMP-2 to detect cirrhosis was higher with sensitivities of 74% and 83% and specificities of 96% and 100%, resulting in a diagnostic efficiency of 92% in the different assays. Plasma TIMP-1 values detect fibrosis with a sensitivity of 52% and 67% and a specificity of 68% and 88% resulting in overall efficiency rates of 68% and 71%, respectively. TIMP-1 values detect cirrhosis with 100% sensitivity but only 56% and 75% specificity. The diagnostic potential of circulating TIMP-1 was similar to that of hyaluronate and better than that of enzymes or albumin values.
Plasma values of TIMP-1 and MMP-2 are able to detect cirrhosis with high sensitivity. TIMP-1 values also detect fibrosis with comparable efficiency. Regular determinations of both TIMP-1 and MMP-2 in CAH patients may be used as indicators of increasing fibrosis and the development of cirrhosis.
研究金属蛋白酶组织抑制剂(TIMP)-1和基质金属蛋白酶(MMP)-2的循环水平,作为慢性肝病纤维化诊断的参数。我们将它们与肝组织学、血清透明质酸和标准肝功能检查相比较,评估其诊断潜力。
采用市售酶联免疫吸附测定法(ELISA)研究慢性丙型肝炎患者(CAH;n = 59)、丙型肝炎病毒所致肝硬化患者(n = 19)和30名健康对照者的TIMP-1和MMP-2循环值(Bindazyme、Biotrak、Quantikine)。根据Ishak等人的方法[《肝脏病学杂志》,22(1995)696 - 699],使用肝炎活动指数评估肝组织学,分别量化炎症活动和纤维化。
不同检测方法的TIMP-1和MMP-2值正常范围不同。然而,各种检测方法显示出相似的诊断能力和线性相关性。MMP-2值在对照组以及有和没有纤维化的CAH患者中相似,但在肝硬化患者中显著升高。TIMP-1值从正常到无纤维化的CAH、有纤维化的肝炎以及肝硬化呈稳步升高。血清MMP-2检测纤维化的诊断潜力较低,在所使用的两种检测方法中敏感性为7%,总体诊断效率分别为56%和58%。循环MMP-2检测肝硬化的潜力较高,敏感性分别为74%和83%,特异性分别为96%和100%,在不同检测方法中诊断效率为92%。血浆TIMP-1值检测纤维化的敏感性分别为52%和67%,特异性分别为68%和88%,总体效率分别为68%和71%。TIMP-1值检测肝硬化的敏感性为100%,但特异性仅为56%和75%。循环TIMP-1的诊断潜力与透明质酸相似,且优于酶或白蛋白值。
TIMP-1和MMP-2的血浆值能够高敏感性地检测肝硬化。TIMP-1值检测纤维化的效率也相当。定期测定CAH患者的TIMP-1和MMP-2可作为纤维化加重和肝硬化发生的指标。